126 results
Page 5 of 7
S-8 POS
EX-99.2
pjad dt8ed18uoccup2
25 Oct 22
Registration of securities for employees (post-effective amendment)
11:42am
6-K
EX-99.1
uxgty
3 Aug 22
Half-Year Report JANUARY – JUNE 2022
4:36pm
6-K
EX-99.1
eamsnwg8ernh67d8
23 Jun 22
First Quarter Interim Statement JANUARY – MARCH
6:30am
S-8
EX-4.4
evduicfavf1vyynj1b
21 Jun 22
Registration of securities for employees
12:17pm
6-K
EX-99.1
w2nylhjpsoc my3d291
13 Jun 22
Current report (foreign)
4:07pm
6-K
EX-99.1
8deeb jceen83jvnf
10 Jun 22
Current report (foreign)
7:16am
6-K
EX-99.1
eb19 wncp0l00mrxaxp
23 Mar 22
Current report (foreign)
4:15pm
6-K
EX-99.1
lxadm1 1o3z5i9iz5f
16 Mar 22
Current report (foreign)
5:13pm
6-K
EX-99.1
2iyeo9at8t0kcxs58h
16 Mar 22
2021 Annual Report A nn ua l R ep or t 20 21
4:55pm
6-K
EX-99.1
wpoglt68rvirt
10 Nov 21
Third Quarter Interim Statement JANUARY – SEPTEMBER
4:05pm
S-8
EX-4.5
x1rr8ey 2tv
27 Oct 21
Registration of securities for employees
11:32am
S-8
EX-4.4
cxwqed lcmkzy8qg
27 Oct 21
Registration of securities for employees
11:32am
CORRESP
dmc7e4ox655 6xn
12 Oct 21
Correspondence with SEC
12:00am
6-K
EX-99.1
u8wfske40uvbh
27 Aug 21
MorphoSys and Incyte Announce the European Commission
6:15am
6-K
EX-99.1
g582a6 9h1r
28 Jul 21
Half-Year Report January – June 2021
5:10pm
SC TO-T/A
EX-99
xsa8ln70mzl6k8
15 Jul 21
Third party tender offer statement (amended)
8:47am
6-K
EX-99.1
9x2wqkv6pxj2n1kr79p
15 Jul 21
MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology
6:22am
SC TO-T
EX-99
ub1z9m9
16 Jun 21
Third party tender offer statement
4:52pm
SC TO-T
EX-99
niia5oyyh9kmlb24s7y2
16 Jun 21
Third party tender offer statement
4:52pm